Several possible studies
Story checked
New project explores treatments to protect the brain from alphavirus infections (opens in a new tab)
news-medical.net · 2026-10-30
Short answer
Several possible studiesStudy not confirmed.
Several potential source studies were identified, but no single match could be confirmed. The article's claims remain unverified.
These papers were considered as possible sources, but none could be confirmed as the study behind this story.
Share this check
The story
New project explores treatments to protect the brain from alphavirus infections
news-medical.net · 2026-10-30
The story’s checkable claims.
Read the original story (opens in a new tab)NewsLink checks it
Multiple potential source studies identified.
Several studies match details in the article, but none could be confirmed as its source. The claims have not been assessed against a source study.
View article claimsSearch result
Several studies could fit.
Several studies match details in the article, but none could be confirmed as its source. The claims have not been assessed against a source study.
Evidence layer
Claim by claim
The article's claims are listed below. Without a confirmed source study, they have not been assessed as supported or unsupported.
Reading mode
Scan verdicts. Open evidence only when needed.
Claim 1 of 1Not checkedDr. Victor Ogungbe is leading a five-year, $3.67 million NIH-funded research project at UAH focused on advancing potential treatments for alphaviruses, which currently have no approved vaccines or therapeutics for human use.View evidenceHide evidence
As statedfive-year, $3.67 million
Not checked
No source study was confirmed for this article. This claim remains unverified, rather than assessed as supported or unsupported.
Method layer
Study not confirmed.
The search results are available for you to inspect. Without a confirmed source study, they cannot establish whether the story’s claims are supported or contradicted.
Search results
Candidate papers, not confirmed sources.
PubMed, Europe PMC, Crossref · 15 candidate papers
A robust FRET-based biochemical assay for the discovery of chikungunya virus nsP2 protease inhibitors.
Journal of Pharmacological and Toxicological Methods · 2026 · PubMed, Europe PMC
nsP2 Protease Inhibitor Blocks the Replication of New World Alphaviruses and Offer Protection in Mice
ACS Infectious Diseases · 2025 · PubMed, Europe PMC, Crossref
N-Alkyl Sulfamates as a New Class of nsP2 Cysteine Protease Inhibitors with Broad Spectrum Antialphaviral Activity.
bioRxiv : the Preprint Server for Biology · 2025 · PubMed
Alphavirus nsP2 protease structure and cleavage prediction: Possible relevance to the pathogenesis of viral arthritis
2022 · Crossref
Chikungunya virus nsP2: Insights into viral replication, pathogenesis, and therapeutic targeting.
2026 · Europe PMC